A panel of outside experts to the U.S. Food and Drug Administration voted against backing the risk-benefit profile of ...
US regulators’ recent decision to scrap a little-used panel of arthritis experts is seen as an unwelcome signal that they don’t expect rapid new developments of novel therapies in rheumatology. The ...
Nearly one in five pregnant women and new moms in this country suffers from anxiety and depression. And 6-8% of pregnant women are prescribed a group of antidepressants called Selective Serotonin ...
The FDA’s Oncologic Drugs Advisory Committee (ODAC) on Thursday voted 6 to 3 that AstraZeneca has not demonstrated its oral ...
Alexander is a practicing internist and drug safety expert at the Johns Hopkins Bloomberg School of Public Health. Americans trust the Food and Drug Administration to make life-and-death decisions in ...
Hosted on MSN
FDA panel promotes misinformation on antidepressants during pregnancy, psychiatrists say
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to misinformation or facts taken out of context, according to several ...
Food and Drug Administration (FDA) commissioner Marty Makary speaks during a news conference on the FDA's intent to phase out the use of petroleum-based synthetic dyes in the nation's food supply at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results